George Eric Davis, EVP, General Counsel at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 30,000 shares at $90.66 ($2.7M) on 2018-02-01, disclosed to the SEC on 2018-02-05.
Open-market sale of $2.7M BMRN by EVP, General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BMRN | SELL | 2024-05-06 | $315K | — | Filing → |
| BMRN | SELL | 2024-04-01 | $4.3M | — | Filing → |
| BMRN | SELL | 2023-12-14 | $2.6M | — | Filing → |